Ongoing HRT patch shortages in Australia have been extended once again, leaving many people relying on transdermal oestrogen therapy facing further delays at the pharmacy counter.
To help ease the disruption, the Therapeutic Goods Administration (TGA) has approved the supply of overseas-registered alternatives across multiple strengths under Section 19A of the Therapeutic Goods Act. Alongside this, a Serious Scarcity Substitution Instrument (SSSI)—currently active until 28 February 2027—remains in place. This allows pharmacists to swap an out-of-stock patch for an equivalent-strength brand, or two half-strength packs of the same brand, without sending you back to your GP for a new prescription.
Who is affected by the HRT patch shortages?
Anyone using transdermal estradiol HRT patches across Australia, as well as the GPs, specialists, and community pharmacists managing their prescriptions.
Updated supply timelines: which patches are affected?
While several strengths have returned to normal supply, key Estradot and Estraderm products remain scarce:
Estraderm MX 100 patches: Shortage extended; normal supply is expected by 30 November 2026.
Estradot 25, 50, 75, and 100 mcg patches: Shortage extended; normal supply is not expected until 30 June 2027.
Shortages resolved: Estradot 37.5 mcg, Estraderm MX 25, 50, and 75 mcg, Estalis Sequi (50/140 and 50/250), and Estalis Continuous (50/140 and 50/250) have all returned to normal supply.
What these HRT patch shortages mean at the pharmacy counter
If your usual brand is unavailable, your pharmacist can discuss suitable alternatives—though out-of-pocket costs can vary depending on which product is dispensed:
Overseas alternatives: Imported alternatives approved under the TGA scheme are available in multiple strengths and generally attract standard PBS pricing.
Estraderm MX 75 mcg: Because this strength is not listed on the PBS, accepting it as an SSSI substitute means paying the full private price with no PBS subsidy.
Overseas-registered Estramon patches (25, 50, 75, 100 mcg): These imported packs contain 24 patches rather than the standard 8 found in Australian-registered boxes. Because of this pack-size difference, they do not receive PBS pricing under the SSSI—you will need a fresh prescription specifically written for Estramon to access the PBS subsidy.
Half-strength substitutions: When a pharmacist supplies two half-strength patches to make up your prescribed dose, they can use PBS authority prescription number
00000246and override PBS Online warning reason code151so your treatment duration stays intact.
Also read: Livestock duty resumes: owners and agents face a 21 November lodgement deadline
General information only, not legal advice. Check the official source before acting.
Source: Therapeutic Goods Administration.






